Member Info for Phantom25

Morgan. I see 1 trade for 1mln , interested to know where you see the other 2

Jelenko I think if you go back and read my post I was confirming your statement that EXAS is a loss maker unlike Hmmm who was suggesting otherwise

EXAS
Revenue is not profit!
Profit for year end 2020 was negative, or a loss of $850 mln

A large pharma wouldn't be buying Parsortix for in house use only, it would be for future profits from the product.
Large pharma Co's are forced to buy minnows if they make substantial profit. There is nothing gained by putting the cash in the bank.

Another thing to consider is that when income starts to roll in A.N. will be looking for more early stage technology under the radar to buy. A lot of new investors probably don't realise that AGL didn't invent Parsortix, they bought it. Likewise the graphics rendering software that eventually got sold to ARM

So using those figures and PE ratio of 20
AGL mkt cap would be 1 to 2 billion SP 4 to £8
All Without FDA approval.
PE of 20 is very conservative. Abbott has a PE of 50

This is of course ignoring cost of sales, but we know they are low, as a cassette only costs £10
Would also have to add lab costs. But it is obvious that we will not get bought for £4

Thanks

Bit easier if on a phone
https://tinyurl.com/s6s7rj2v

Are you suggesting that if a likely large company, say Abbott(mkt cap 220 billion) for example, bought Parsortix that's it's SP would multiply up as a result. It wouldn't happen. Parsortix sales for Abbott would be a drop in the ocean when combined with its other revenue income, And the same would would apply to any other large pharma, you would have to share the success of Parsortix sales with all the other umpteen millions of share holders. And the issue of Andrew's massive share bonus on SP, he knows he will hit it without selling the company for 4 quid

MissBMW I can't remember exactly how long I have been here, some time around 2008 I think. Talking of people who believed in A.N., what happened to HickoryDickory

There will be no requirement for Dr Novo classified approvals for further cancer types. At most they will need only a 510k submission I would think

Angle has been Andrews baby for about 20 years, if he had put his money in in an average fund he would earned a lot more than selling Angle for £4 a share. So why would he do it

Quotes now are 2p over ask

Yes, perhaps they are opening up the morning post, announcing them one by one -:)

Currently over 2000 trials in operation, and after only 2 weeks of the labs opening we have signed one up. Looking promising.

Not for research use, only direct patient use

All things considered, the fact that the SP has only dropped back to where it was 10 days ago shows the strong sentiment here. And look at the positive side, we now have a new RNS to look forward to, 'Exports resumed'

Not looking good only 1.3% vaccinated. Maybe open a short on the Olympics

No one knows if a trade is a buy or sell, it is estimated on the price traded is it higher or lower than the midway price at the time. If your broker publishes stats for it's client trades via MMs you can use that as a benchmark because they know what you have traded. Also, for the SETS trades(no MM involved) there is no such thing as a buy or sell as one side of the trade has sold and the other has bought

To me it seems an irrelevant test to carry out on a company that is not in full production, what books is it trying to cook? None. One of the best tests for a share that is going places, is to note the arrival of interest from those with a 3 day old account asking questions with a negative slant

Think I saw £125 somewhere on the site